白介素-6与内皮素-1受体在面部色斑黑素细胞树突增多中的作用及烟酰胺和氨甲环酸的抑制作用
该研究通过激光显微切割转录组分析发现,面部色斑(黄褐斑、日光性黑子、炎症后色素沉着)皮损中IL-6受体和ET-1受体显著上调,且黑素细胞树突增多;体外实验证实IL-6和ET-1增加黑素细胞树突性和黑素小体转移,烟酰胺和氨甲环酸可抑制角质形成细胞释放IL-6/ET-1,SDL直接抑制树突性。
要点
- 面部色斑中IL-6R和ET-1R表达上调,黑素细胞树突增多。
- IL-6和ET-1在体外增加黑素细胞树突性和黑素小体转移。
- 烟酰胺和氨甲环酸抑制角质形成细胞释放IL-6/ET-1,SDL直接抑制树突性。
核心结论
- IL-6和ET-1受体在多种面部色斑中显著上调,其配体在体外增加黑素细胞树突性。
- 受试美白化合物可减少角质形成细胞释放IL-6/ET-1和/或抑制黑素细胞树突性。
- 该工作揭示了面部色斑的病理生理机制及美白化合物的潜在新机制,需进一步人临床验证。
研究设计与样本
- 收集中国女性(年龄20-70岁)面部色斑(黄褐斑、日光性黑子、痤疮诱导的炎症后色素沉着)及邻近非色斑皮肤活检。
- 激光显微切割表皮浅层和基底层以富集角质形成细胞或黑素细胞进行转录组分析。
- 免疫荧光染色评估黑素细胞树突性。
- 在人黑素细胞或黑素细胞-角质形成细胞共培养模型中评估IL-6和ET-1对树突性和黑素小体转移的影响。
- 评估美白化合物(烟酰胺、氨甲环酸、蔗糖月桂酸酯/二月桂酸酯混合物SDL)对IL-6或ET-1释放及黑素细胞树突性的影响。
主要发现
- 转录组分析显示,与邻近正常皮肤相比,色斑区IL-6受体和ET-1受体显著上调,免疫染色在蛋白水平视觉确认。
- 色斑区黑素细胞比邻近非色斑皮肤黑素细胞树突更多。
- 在细胞培养模型中,加入IL-6和ET-1增加黑素细胞树突性和黑素小体转移。
- 烟酰胺及其组合显著抑制IL-6释放,烟酰胺和氨甲环酸均显著减少ET-1释放。
- SDL直接作用于黑素细胞以减少树突性。
临床怎么用
- 烟酰胺和氨甲环酸可能通过抑制角质形成细胞释放IL-6/ET-1改善面部色斑。
- SDL可能直接抑制黑素细胞树突性,为美白提供新途径。
- 上述机制需进一步人临床验证后方可指导临床实践。
局限性
- 研究主要基于体外细胞模型,需人临床验证。
- 样本仅来自中国女性,年龄20-70岁,外推性受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hyperpigmented spots are common issues in all ethnicities with a hallmark characteristic of increased melanocyte dendricity. OBJECTIVES: To determine (1) potential receptors and/or cytokines that are involved in increased melanocyte dendricity in multiple facial spot types; (2) treatment effects of skin-lightening compounds on identified cytokine release from keratinocytes and on dendricity in melanocytes. METHODS: Facial spots (melasma, solar lentigo, acne-induced post-inflammatory hyperpigmentation) and adjacent non-spot skin biopsies were collected from Chinese women (age 20-70). The epidermal supra and basal layers were laser dissected to enrich keratinocyte or melanocyte biology respectively for transcriptome analysis. Melanocyte dendricity was assessed histologically by immunofluorescent staining. Effect of interleukin-6 (IL-6) and endothelin-1 (ET-1) on melanocyte dendricity and melanosome transfer were assessed in human melanocytes or melanocyte-keratinocyte co-culture models. Treatment effects of skin-lightening compounds (niacinamide, tranexamic acid [TxA], sucrose laurate/dilaurate mixture [SDL]) were assessed on IL-6 or ET-1 release from keratinocytes and on dendricity in melanocytes. RESULTS: Transcriptome analysis revealed IL-6 receptor and ET-1 receptor were significantly upregulated compared to the adjacent normal skin, visually confirmed at the protein level through immunostaining. Melanocytes in spot areas are more dendritic than melanocytes in adjacent non-spot skin. The addition of IL-6 and ET-1 to cell culture models increased melanocyte dendricity and melanosome transfer. IL-6 release was significantly suppressed by niacinamide and its combination, while ET-1 release was significantly reduced by both niacinamide and TxA. In contrast, SDL acted directly upon melanocytes to reduce dendricity. CONCLUSION: Interleukin-6 and ET-1 receptors are significantly upregulated in multiple facial spot types. The in vitro testing demonstrated their respective ligands increased melanocyte dendricity. Tested skin-lightening compounds showed reduction in release of IL-6/ET-1 from epidermal keratinocytes and/or inhibition of melanocyte dendricity. This work sheds light on pathophysiological mechanism of facial spots and potential new mechanisms of these skin-lightening compounds which warrant further human clinical validation.
引用
- Hakozaki T, Wang J, Laughlin T, et al. Role of interleukin-6 and endothelin-1 receptors in enhanced melanocyte dendricity of facial spots and suppression of their ligands by niacinamide and tranexamic acid. J Eur Acad Dermatol Venereol. 2024. PMID: 38116639. doi:10.1111/jdv.19719
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。